The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
NCT04679324 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-11-29
Summary
The study is being done to identify types of bacteria associated with the lining of the large intestine in people who have recently been diagnosed with C. difficile infection to determine if there are features associated with development, clearance, and recurrence of disease.
Conditions
- Clostridioides Difficile Infection
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Purna Kashyap, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-23
- Primary Completion
- 2022-08-10
- Completion
- 2022-08-10
More Related Trials
-
FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI
NCT02255305 ·Status: TERMINATED ·Phase: PHASE2
-
Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).
NCT04626947 ·Status: TERMINATED ·Phase: PHASE4
-
Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea
NCT01868373 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Flagyl Microbiome in Crohn's Disease
NCT04682522 ·Status: COMPLETED ·Phase: PHASE4
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
FMT in Uncomplicated Diverticulitis
NCT05373784 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
NCT07250724 ·Status: RECRUITING
-
Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection
NCT02403622 ·Status: TERMINATED ·Phase: PHASE2
-
Immune Response to C.Difficile Infection
NCT02797288 ·Status: UNKNOWN
-
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection
NCT04100603 ·Status: WITHDRAWN
-
LMN-201 for Prevention of C. Difficile Infection Recurrence
NCT05330182 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Clostridioides Difficile Controlled Human Infection Model
NCT06702345 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
NCT00304876 ·Status: COMPLETED
-
Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)
NCT03005379 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Mucosal and Microbiota Changes During Acute Campylobacteriosis
NCT03223077 ·Status: RECRUITING
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis
NCT01973465 ·Status: UNKNOWN ·Phase: NA
-
Mucosal Versus Fecal Microbiota in FMT
NCT02133651 ·Status: COMPLETED
-
Pathogenic Mechanisms in C Diff Infection and Colitis
NCT01930032 ·Status: COMPLETED
-
Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection
NCT04885946 ·Status: UNKNOWN ·Phase: NA
-
C.Difficile Observational Study
NCT06277999 ·Status: COMPLETED
-
Study on Clostridium Difficile Infection in Chinese Patients With Inflammatory Bowel Disease
NCT04179201 ·Status: UNKNOWN
-
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
NCT01259726 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History of Clostridioides Difficile Infection
NCT04801862 ·Status: RECRUITING
-
Fecal Transplant for Relapsing C. Difficile Infection
NCT01703494 ·Status: UNKNOWN ·Phase: PHASE2
-
Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum
NCT01704937 ·Status: COMPLETED ·Phase: PHASE1